Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

Grants

Funding Acknowledgements

The authors thank the participants in the study, Professor Jenny Hoy, the Clinical Research nursing staff, Kerry Watson and Scott Bowden for assistance with participant recruitment and sample analysis. We acknowledge funding from the NHMRC Centre for Clinical Research Excellence in Infectious Diseases, The University of Melbourne and the National Institute of Health (grant RO1 A1060449).